Decreased expression of hsa-miR-4274 in cerebrospinal fluid of normal pressure hydrocephalus mimics with parkinsonian syndromes

Manuscript Number: 

16-0848R1

Author(s): 
Chihiro Akiba, Hajime Arai, Nobutaka Hattori, Ivana Jurjević, Mitsuyasu Kanai, Mika Kikkawa, Akihide Kondo, Masakazu Miyajima, Madoka Nakajima, Ikuko Ogino

Disclosures

Chihiro Akiba

  • Nothing to Disclose

Hajime Arai

  • Nothing to Disclose

Nobutaka Hattori

  • Lecture Fees:
    GlaxoSmithKleine K.K, Nippon Boehringer Ingelheim,Co.,Ltd, FP Pharmaceutical Corporation, Dai-Nippon Sumitomo Pharma Co.,Ltd., Eisai Co.,Ltd. , Kissei Pharmaceutical Company, Nihon Medi-physics Co.,Ltd., Kyowa Hakko-Kirin Co.,Ltd., Novartis Pharma K.K.
    Sponsors:
    Nihon Medi-physics Co.,Ltd.
    Patents/Royalties
    Biogen, Acorda Therapeutics, Inc.
    Grants
    • Agency: 
      Nihon Medi-physics Co.,Ltd.
      Dates: 
      Sep. 9, 2015

Ivana Jurjević

  • Nothing to Disclose

Mitsuyasu Kanai

  • Nothing to Disclose

Mika Kikkawa

  • Nothing to Disclose

Akihide Kondo

  • Nothing to Disclose

Masakazu Miyajima

  • Nothing to Disclose

Madoka Nakajima

  • Nothing to Disclose

Ikuko Ogino

  • Nothing to Disclose